Cargando…
Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
The corona virus disease-19 (COVID-19) pandemic has affected the entire world causing huge economic losses and considerable morbidity and mortality. Considering the explosive growth of the pandemic repurposing existing medicines may be cost-effective and may be approved for use in COVID-19 faster. R...
Autores principales: | Shankar, Pathiyil Ravi, Palaian, Subish, Gulam, Shabaz Mohiuddin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142918/ https://www.ncbi.nlm.nih.gov/pubmed/34084043 http://dx.doi.org/10.4103/jpbs.JPBS_404_20 |
Ejemplares similares
-
Therapeutic Dimensions of Bisphosphonates: A Clinical Update
por: Vannala, Venkataramana, et al.
Publicado: (2020) -
Risk Perception and Hesitancy Toward COVID-19 Vaccination Among Healthcare Workers and Staff at a Medical College in Nepal
por: Paudel, Sabita, et al.
Publicado: (2021) -
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020) -
Knowledge and Practice on Ecopharmacovigilance and Medicine Storage Amongst Medical and Dental Students in Lalitpur, Nepal
por: Jha, Nisha, et al.
Publicado: (2021) -
Non-Pharmacological Infection Prevention and Control Interventions in COVID-19: What Does the Current Evidence Say?
por: Shankar, P. Ravi, et al.
Publicado: (2021)